Patents Examined by Chris R Tate
  • Patent number: 9585923
    Abstract: The present invention relates to an antioxidant, anti-inflammatory or anti-aging composition containing any one or more of a Taxus cambium- or procambium-derived cell line, an extract thereof, a lysate thereof and a culture medium thereof. The composition according to the present invention has minimized side effects compared to existing antioxidants and anti-inflammatory agents, is involved in intracellular metabolism to reduce intracellular reactive oxygen species, and reduces and induces aging-related signals. Thus, the composition of the preset invention is useful for preventing and delaying aging. In addition, the composition of the present invention has the effect of inhibiting melanogenesis, and thus is useful as a whitening cosmetic composition.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: March 7, 2017
    Assignee: UNHWA CORPORATION
    Inventors: Dae Hee Lee, Eun Kyong Lee, Eun Mi So, Young Woo Jin
  • Patent number: 9585904
    Abstract: The present invention relates to a novel method for processing a cultured root of purple wild ginseng for increasing saponin content and to the cultured root of the purple wild ginseng which is processed thereby. The present invention can provide the cultured root of wild ginseng having significantly higher content of a specific ginsenoside, and can increase the productivity and economic efficiency by simplifying the production process.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: March 7, 2017
    Inventor: Hong Sik Lee
  • Patent number: 9585852
    Abstract: The invention is dietary supplements, nutraceutical compositions, medical foods, and animal feeds that have cytoprotective (cell and tissue protection) and health promoting effects. The compositions contain a high dose range of agmatine and nutraceutical acceptable salts thereof as dietary fortification for providing effective long-term cytoprotection and affording for soft stool. The compositions may contain agmatine alone or in combination with other dietary ingredients having health promoting effects. The compositions can be prepared with dietary accepted excipients and compatible forms of carriers, including but not limited to, powders, tablets, capsules, controlled release carriers, lozenges and chewable preparations, liquid suspensions, suspensions in an edible supporting matrix or foodstuff and oral rehydration solutions, to enable consumption of said compositions.
    Type: Grant
    Filed: December 1, 2014
    Date of Patent: March 7, 2017
    Inventors: Gad Gilad, Varda Gilad
  • Patent number: 9585919
    Abstract: The present invention relates to a novel liquid preparation for the topical treatment for itching and inflammation associated with psoriasis and other common skin maladies wherein a layered mass of organic and inorganic material comprising: 1) Fruits, vegetable by-products, and paper scraps; 2) Grit comprising a blend of crushed volcanic rock; and, 3) A microbial soil enhancer is composted by a population of selected earthworms. The composting mass is misted daily to achieve a uniformly moist consistency. For the first two weeks, any worm tea (runoff) exiting the composting mass after each daily misting is recycled into the next day's misting fluid. A fraction of the worm tea produced during the third through twelfth weeks is harvested, pH adjusted, and treated with surfactant to form the liquid preparation.
    Type: Grant
    Filed: March 9, 2014
    Date of Patent: March 7, 2017
    Inventors: Charles W Moro, Ron Moro
  • Patent number: 9585927
    Abstract: The invention provides a composition comprising a mixture of extracts obtained from Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophylla, and Viola philippica. The present invention further provides a method for treating metastatic breast cancer in a subject in need thereof, comprising: administering to said subject an pharmaceutically effective amount of the composition.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: March 7, 2017
    Assignee: MERIYANA BIO MANAGEMENT B.V.
    Inventor: Chih Hui Lin
  • Patent number: 9585926
    Abstract: Described is a method of treating a skin condition in a subject. The method includes applying topically to the subject an effective amount of an aqueous Astragalus seed extract solution to a skin area in need of reducing or slowing the skin condition. The aqueous Astragalus seed extract solution is prepared by a procedure including the steps of: soaking dried seeds of Astragalus seed in an aqueous solvent to form a suspension; boiling the suspension for at least 30 minutes; and filtering the suspension so as to obtain the Astragalus seed aqueous extract solution, the weight ratio of the dried seeds of Astragalus seed to the extract solution being 1:100 to 75:100.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: March 7, 2017
    Assignee: Nefeli Corporation
    Inventor: Ping Zhang
  • Patent number: 9579355
    Abstract: The present invention is a composition and method of treatment for actinic purpura, skin disorders, and skin conditions in general through topical systematic and periodic application of a formulation that generally may include ingredients to improve circulation such as but not limited to arnica oil CLR and phytotonine; ingredients to thicken the skin such as but not limited to retistar, glycolic acid, vitamin K1, and phyto-age; and ingredients to repair the skin's barrier, such as but not limited to timecode, SKINMIMICS, ABS pomegranate sterols, and pentatavitin.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: February 28, 2017
    Assignee: Clark Pharmaceuticals LLC
    Inventors: Stephen W. Clark, Natalie Barger
  • Patent number: 9579298
    Abstract: Compositions and methods for maintaining healthy skin and alleviating skin conditions such as redness, inflammation, irritation and skin aging, as well as for maintaining healthy scalp and hair are disclosed. The oral compositions disclosed comprise antioxidants including lycopene, gallic acid and ascorbic acid. Preferably lycopene has been water-extracted, more preferably under acid conditions. In the method of treatment aspect of the invention, an oral composition containing antioxidant(s) is administered to a person concurrently with a topical treatment for said skin conditions. Preferred topical compositions comprise cyclohexane polyols, such as cyclohexanediol or cyclohexanetriol.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: February 28, 2017
    Inventor: Piotr Chomczynski
  • Patent number: 9579278
    Abstract: The present invention relates to a skin care composition comprising an extract of Bursera simaruba seeds and a cosmetically acceptable topical carrier. Such composition is useful for improving skin barrier function and moisturization as well as improving signs of skin aging.
    Type: Grant
    Filed: May 10, 2013
    Date of Patent: February 28, 2017
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Suhyoun Chon, Ya-Ping Hu, Khalid Mahmood, Apostolos Pappas, Ramine Parsa, Kurt A. Reynertson, Michael D. Southall
  • Patent number: 9580668
    Abstract: It is provided a process for producing a purified essential oil excellent in safety and quality with high productivity from an essential oil comprising a harmful contaminant such as an agricultural chemical by simply and smoothly removing the contaminant with high removal rate without causing poor balance of flavor which the essential oil originally has, decrease of flavor strength and the like. It relates to a process for producing a purified essential oil by treating an essential oil comprising a contaminant with an active carbon to remove the contaminant and the removal rate of the contaminant is further improved by using an active carbon activated with a chemical, particularly an active carbon activated with zinc chloride, in the treatment, or by conducting the treatment at a low temperature of room temperature or lower, particularly at ?25° C. to 5° C.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: February 28, 2017
    Assignee: TAKASAGO INTERNATIONAL CORPORATION
    Inventors: Ryo Takeuchi, Shigemasa Oshikubo
  • Patent number: 9580687
    Abstract: Disclosed is a method for culturing mesenchymal stem cells, comprising culturing mesenchymal stem cells in a medium containing calcium in a concentration of from 2.1 to 3.8 mM and magnesium in a concentration of from 1.0 to 3.0 mM under a hypoxic condition of 2 to 5% oxygen. The culturing method can increase the population of mesenchymal stem cells even with a small number of passages by improving mesenchymal stem cells in proliferative capacity and viability. In addition, the mesenchymal stem cells prepared by the culturing method are effectively used not only as a safe cell therapeutic agent due to their lacking immunogenicity, but also as a cartilage regenerating medicine owing to their excellent secretion of cytokines.
    Type: Grant
    Filed: September 2, 2013
    Date of Patent: February 28, 2017
    Assignee: Medipost Co., Ltd.
    Inventors: Yoon-Sun Yang, Won Il Oh, Sun Jae Kwon, Mi Yeon Lee, Hong Bae Jeon
  • Patent number: 9579354
    Abstract: Provided herein are methods of using therapeutically effective compositions of sandalwood oil to treat, prevent or reduce the recurrence of Clostridium infections.
    Type: Grant
    Filed: January 23, 2013
    Date of Patent: February 28, 2017
    Assignee: Santalis Pharmaceuticals, Inc.
    Inventors: Ian Clements, Paul Castella, Corey Levenson
  • Patent number: 9572911
    Abstract: The subject invention pertains to materials and methods for processing tissue to produce a natural, acellular replacement tissue that is immunocompatible with a recipient. According to the subject invention, harvested tissue is subjected to wash solutions wherein only amphoteric detergent(s) are used (e.g., anionic detergents are excluded). Following extraction by amphoteric detergent(s), the tissue is washed with a buffer system to facilitate the clearance of cellular components and detergent. In one embodiment, the subject invention pertains to a replacement tissue that is a nerve graft that supports axonal regeneration, guides axons toward the distal nerve end and/or is immunologically tolerated. Preferably, the nerve graft retains essential extracellular matrix scaffolding as well as biological components that promote nerve regeneration through the nerve graft.
    Type: Grant
    Filed: March 17, 2014
    Date of Patent: February 21, 2017
    Assignee: University of Florida Research Foundation, Incorporated
    Inventor: David F. Muir
  • Patent number: 9572827
    Abstract: A pharmaceutical composition for treating depression and method for preparation thereof is provided. The pharmaceutical composition includes Radix Ginseng, Radix Glycyrrhizae, and/or their aqueous or alcoholic extract. Fructus Jujubae or their aqueous or alcoholic extract can also be included in the pharmaceutical composition.
    Type: Grant
    Filed: November 11, 2013
    Date of Patent: February 21, 2017
    Assignees: Beijing Wonner Biotech. Ltd. Co.
    Inventor: Zuoguang Zhang
  • Patent number: 9572847
    Abstract: The invention discloses an herbal extract of treating lung tumor. The herbal extract comprises Antrodia cinnamomea and Cordyceps militaris, and the herbal extract is manufactured as following: mingling Antrodia cinnamomea and Cordyceps militaris with a weight ratio being between 1:5 and 5:1 to obtain a mixture; blending the mixture with a solvent with a weight-volume percentage being 50%, followed by extracting at 40-90° C. to obtain a herbal solution; and concentrating the herbal solution to obtain the herbal extract.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: February 21, 2017
    Assignee: Kingland Property Corporation, Ltd.
    Inventors: Wei-Cheng Chen, Mei-Chou Lai, Shorong-Shii Liou, I-Min Liu
  • Patent number: 9568467
    Abstract: Identification and use of compounds which inhibit the expression or activity of micro-RNAs for preventing and/or attenuating ageing. An in vitro method for screening for candidate compounds for preventing and/or attenuating ageing of the skin including (a) bringing at least one test compound in contact with a sample of fibroblasts, (b) measuring the expression or the activity of at least one microRNA chosen from miR-134 and miR-152 in said fibroblasts, and (c) selecting the compounds for which an inhibition of at least 20%, preferably at least 30%, preferably at least 40% of the expression or an inhibition of at least 20%, preferably at least 30%, preferably at least 40% of the activity of at least one microRNA is measured in the fibroblasts treated in (a) compared with the untreated fibroblasts.
    Type: Grant
    Filed: August 28, 2013
    Date of Patent: February 14, 2017
    Assignee: CHANEL PARFUMS BEAUTE
    Inventors: Eleonora Candi, Gerry Melino, Gaelle Saintigny, Christian Mahe
  • Patent number: 9566309
    Abstract: Disclosed are compositions containing extracts of (a) Panax ginseng C. A. Mayer, (b) Zingiber officinale, (c) Echinacea angustifolia and (d) Silybum marianum or the phospholipid complex of silybin with phospholipids as active ingredients, mixed with suitable excipients.
    Type: Grant
    Filed: July 11, 2013
    Date of Patent: February 14, 2017
    Assignee: INDENA S.P.A.
    Inventors: Ezio Bombardelli, Fabrizio Corti
  • Patent number: 9561244
    Abstract: A method for treating, preventing or ameliorating breast cancer is provided by administering a synergistic amount of digitoxin and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be paclitaxel. Methods for treating or preventing a neoplasia using a synergistic combination, and compositions of a synergistic combination of a cardiac glycoside and either actein or an extract of black cohosh comprising triterpene glycosides, and optionally another chemopreventive agent which may be a taxane are also provided. The compositions may also be used in a method for modulating Na+K+ATPase activity. In addition, a method for inhibiting the progression or development of breast cancer in vivo by administering either actein or an extract of black cohosh comprising triterpene glycosides and optionally at least one other chemoprotective agent is provided.
    Type: Grant
    Filed: December 30, 2011
    Date of Patent: February 7, 2017
    Assignee: RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK
    Inventor: Linda Saxe Einbond
  • Patent number: 9555069
    Abstract: The present disclosure describes pharmaceutical compositions and methods for reducing duration, intensity, and/or bothersomeness of common colds in humans and for reducing severity or duration of common cold symptoms such as nasal congestion, runny nose, watery eyes, dry/scratchy throat and sneezing in humans exhibiting such symptoms. The compositions herein comprise extracts of at least one of Luffa Operculata (L. operculata), S. officinale (V. sabadilla), and Galphimia Glauca (G. glauca) in a pharmaceutically acceptable carrier, and in various embodiments, comprise a mixture of all three Luffa Operculata (L. operculata) 10% extract MT, S. officinale (V. sabadilla) 3× extract, and Galphimia Glauca (G. glauca) 10% extract MT in a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: January 31, 2017
    Assignee: MATRIXX INITIATIVES, INC.
    Inventors: Timothy L. Clarot, Arlene M. Ascarate
  • Patent number: 9554985
    Abstract: An agent for promoting hair growth and a preparation method for the same are provided. The method for preparing an agent for promoting hair growth that includes: (1) preparing an extract from eight medicinal herbs combined together at an optimal combination ratio to contain 50 to 70 wt. % of Rumex japonicas HOUTT, 3 to 6 wt. % of Pleuropterus multiflorus, 1 to 2 wt. % of Radix Notoginseng, 1 to 2 wt. % of safflower (Carthamus tinctorius L.), 1 to 2 wt. % of Cnidium officinale, 0.5 to 1 wt. % of Mentha Arvensis var. Piperascens, 0.5 to 1 wt. % of Asarum sieboldii, and 0.5 to 1 wt. % of Glycyrrhiza uralensis Fischer; and (2) adding 10 to 15 wt. % of a purified horse fat to the extract.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: January 31, 2017
    Assignee: KERATINT KOREA CO., LTD.
    Inventors: Byung-Seung Noh, Se-Eung Noh